Ignite Creation Date:
2024-05-06 @ 7:05 PM
Last Modification Date:
2024-10-26 @ 3:00 PM
Study NCT ID:
NCT05890924
Status:
COMPLETED
Last Update Posted:
2023-09-06
First Post:
2023-05-26
Brief Title:
Intimate Partner Violence as a Risk Factor for Venous Thromboembolism in Women
Sponsor:
Centre Hospitalier Universitaire de Nīmes
Organization:
Centre Hospitalier Universitaire de Nīmes
Study Overview
Official Title:
WAST-VTE Intimate Partner Violence as a Risk Factor for Venous Thromboembolism in Women on Combined Oral Contraceptives a Matched Case-control Study
Status:
COMPLETED
Status Verified Date:
2023-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
WAST-VTE
Brief Summary:
The frequency of violence against women or intimate partner violence IPV is more and more underlined and recognized as a cofactor favoring certain somatic and psychic pathologies However its incidence in patients with venous thromboembolism VTE is unknown and its status as a risk factor is still elusive and ambiguous
Investigators therefore conducted a matched case-control study consisting of women taking combined oral contraceptives COC who were investigated and followed up between 2010 and 2020
The cases are the patients investigated for their first venous thromboembolic event The controls were women free of thrombosis who had regular gynecological checkups Case-control pairs were matched on region of residence age - 2 years duration of COC intake - 4 months COC type 2nd 3rd or 4th generation
Investigators therefore conducted a matched case-control study consisting of women taking combined oral contraceptives COC who were investigated and followed up between 2010 and 2020
The cases are the patients investigated for their first venous thromboembolic event The controls were women free of thrombosis who had regular gynecological checkups Case-control pairs were matched on region of residence age - 2 years duration of COC intake - 4 months COC type 2nd 3rd or 4th generation
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None